Clinical trial

WEUSKOP5723: Prostate Cancer Study

NCT01767363

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-11-01

PhaseN/A

Study timeline

Study start (unknown)2012-11-01Date precision: month

Registry last updated2016-11-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Hyperplasiaunresolved

Interventions

5-alpha reductase inhibitorsOTHER

Alpha-blockersOTHER

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01767363 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.